BG
Bellevue Group Portfolio holdings
AUM
$4.81B
1-Year Est. Return
29.28%
1 Year Est. Return
+29.28%
AUM
$4.54B
AUM Growth
+$74.3M
(+1.7%)
Holding
155
Top Buys
| 1 | +$39.2M | |
| 2 | +$38.3M | |
| 3 | +$36.5M | |
| 4 |
Thermo Fisher Scientific
TMO
|
+$20M |
| 5 |
Edgewise Therapeutics
EWTX
|
+$17.7M |
Top Sells
| 1 | +$35.5M | |
| 2 | +$29.9M | |
| 3 | +$25.6M | |
| 4 |
Boston Scientific
BSX
|
+$20M |
| 5 |
Cencora
COR
|
+$19M |
Sector Composition
| 1 | Healthcare | 99.88% |
| 2 | Technology | 0.01% |
| 3 | Consumer Discretionary | 0.01% |
| 4 | Communication Services | 0.01% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Transmedics
TMDX
$3.93B
| $17.5M | 0.39% |
130,517
-43,193
|
|
||
52
Encompass Health
EHC
$11.4B
| $16.2M | 0.36% |
131,741
-41,137
|
|
||
53
Hologic
HOLX
$16.5B
| $16.2M | 0.36% |
247,886
|
|
||
54
Exact Sciences
EXAS
$12.7B
| $15.1M | 0.33% |
284,201
-294,873
|
|
||
55
Masimo
MASI
$8.12B
| $15.1M | 0.33% |
89,673
+19,865
|
|
||
56
CareDx
CDNA
$820M
| $14.7M | 0.32% |
752,371
-136,632
|
|
||
57
Privia Health
PRVA
$2.88B
| $14.5M | 0.32% |
630,697
-66,611
|
|
||
58
Regeneron Pharmaceuticals
REGN
$72.9B
| $14M | 0.31% |
26,744
-1,779
|
|
||
59
Annexon
ANNX
$324M
| $12.4M | 0.27% |
5,157,290
|
|
||
60
Humana
HUM
$28.5B
| $12M | 0.26% |
49,124
+20,826
|
|
||
61
MacroGenics
MGNX
$94.9M
| $12M | 0.26% |
9,919,992
-9,971
|
|
||
62
Johnson & Johnson
JNJ
$472B
| $10.4M | 0.23% |
68,211
+1,202
|
|
||
63
SI-BONE Inc
SIBN
$756M
| $10.2M | 0.22% |
540,112
-332,879
|
|
||
64
Inspire Medical Systems
INSP
$2.51B
| $9.82M | 0.22% |
75,660
-23,367
|
|
||
65
Labcorp
LH
$22.1B
| $9.63M | 0.21% |
36,692
+8,551
|
|
||
66
Phreesia
PHR
$1.3B
| $9.45M | 0.21% |
332,016
-44,147
|
|
||
|
ONC
67
BeOne Medicines Ltd
ONC
$40.5B
| $9.37M | 0.21% |
38,698
+3,369
|
|
||
68
Quest Diagnostics
DGX
$20.8B
| $8.72M | 0.19% |
+48,567
|
|
||
69
BioMarin Pharmaceuticals
BMRN
$10.5B
| $8.32M | 0.18% |
151,445
-216,928
|
|
||
70
Insmed
INSM
$41.2B
| $8.19M | 0.18% |
81,397
-69,153
|
|
||
71
Centene
CNC
$17.9B
| $7.56M | 0.17% |
139,310
+53,092
|
|
||
72
Structure Therapeutics
GPCR
$2.23B
| $7.23M | 0.16% |
348,527
+126,812
|
|
||
73
Teva Pharmaceuticals
TEVA
$29.2B
| $7.06M | 0.16% |
421,501
+392,571
|
|
||
74
Black Diamond Therapeutics
BDTX
$228M
| $6.78M | 0.15% |
2,733,547
|
|
||
75
Amgen
AMGN
$181B
| $6.73M | 0.15% |
24,108
-56,827
|
|